Results 21 to 30 of about 37,349 (258)

Measuring quality in primary healthcare – opportunities and weaknesses

Slovenian Journal of Public Health, 2019
The easy access to data from electronic patient records has made using this type of data in pay-for-performance systems increasingly common. General practitioners (GPs) throughout Europe oppose this for several reasons. Not all data can be used to derive
Arvidsson Eva, Dijkstra Rob, Klemenc-Ketiš Zalika   +2 more
doaj   +1 more source

Addressing Pressing Needs in the Development of Advanced Therapies

Frontiers in Bioengineering and Biotechnology, 2017
The commercial development of advanced therapy medicinal products (ATMPs) represents great opportunity for therapeutic innovation but is beset by many challenges for its developers. Although the ATMP field continues to progress at a rapid pace, evidenced
David Morrow, Anton Ussi, Giovanni Migliaccio   +2 more
doaj   +1 more source

Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria [PDF]

Journal of Liver Cancer
This survey aimed to collect expert opinions from multidisciplinary specialists involved in the management of hepatocellular carcinoma (HCC) in Korea regarding real-world criteria for systemic therapy indications.
Hyun Yang, Soon Sun Kim, Seong Hee Kang, Jieun Kwon, Do Young Kim, Eunju Kim, Hyun Phil Shin, Jeong Il Yu, Jeong-Ju Yoo, Eileen L. Yoon, Sangheun Lee, Young Eun Chon, Janghan Jung, Jaekyung Cheon, Woosun Choi, Seul Ki Han, Ji Eun Han, Moon Haeng Hur, Hyun Woong Lee, Hyung Joon Kim   +19 more
doaj   +1 more source

Reimbursement of care does not equal the distribution of hospital resources: an explorative case study on a missing link among Dutch hospitals

BMC Health Services Research, 2023
Background Affordability and accessibility of hospital care are under pressure. Research on hospital care financing focuses primarily on incentives in the financial system outside the hospital.
L. V. L. van Leeuwen, R. Mesman, H. J. J. M. Berden, P. P. T. Jeurissen   +3 more
doaj   +1 more source

AVAILABILITY OF MEDICINES AS A RESULT OF REIMBURSEMENT MECHANISMS AND MEDICAL INSURANCE IS AN ISSUE FOR DISCUSSION

Constitutional State, 2023
Availability of medicines, their quantity, quality, and appropriate documentation organization regarding distribution, storage, and sales – is one of the priority tasks of the healthcare system of each country. In European Union countries, a significant portion of expenditures for ensuring pharmaceutical supplies is covered by the state, implementing ...
V. I. Truba, N. S. Vasilevska
openaire   +3 more sources

The impact of funding models on the integration of Ontario midwives: a qualitative study

BMC Health Services Research, 2023
Background Nearly 30 years post legalisation and introduction, midwifery is still not optimally integrated within the health system of Canada’s largest province, Ontario. Funding models have been identified as one of the main barriers.
Elizabeth K. Darling, Sylvie B. Lemay, ‘Remi Ejiwunmi, Katherine J. Miller, Ann E. Sprague, Rohan D’Souza   +5 more
doaj   +1 more source

Information and support to patients when the waiting time guarantee cannot be fulfilled: a qualitative study

International Journal for Equity in Health, 2023
Background Long waiting times for health care services are a prominent health policy issue. Waiting time guarantees may limit time to assessment and treatment.
Belén Casales Morici, Hanna Augustsson, Henna Hasson, David Ebbevi   +3 more
doaj   +1 more source

Exploratory analysis on payment mechanisms to Community Mental Health Centers in Chile using mixed grounded theory

Medwave
Introduction Research on psychiatric deinstitutionalization has neglected that reforms in this field are nested in a health system that has undergone financial reforms.
Olga Toro-Devia, Ruben Alvarado, Mercedes Jeria, Denise Razzouk, Luis Salvador-Carulla   +4 more
doaj   +1 more source

A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target–driven treatment regimens in oncology

Acta Oncologica
Background and purpose: Molecularly targeted cancer therapies challenge conventional health economic evaluation frameworks that are structured around tumour-specific indications, comparators, and trial designs.
Oskar Frisell, Eline Aas, Pia Sofie Henkel, Gro Live Fagereng, Kjetil Taskén, Ebba Hallersjö Hult, Peter Lindgren, Katarina Steen Carlsson   +7 more
doaj   +1 more source

A comparative analysis of pricing and reimbursement systems between Italy and Bulgaria [PDF]

Pharmacia
Pricing and reimbursement in the European Union (EU) are unified by Directive 89/105/EEC/21.12.1988. The directive has a framework nature; it defines deadlines for decision-making, legal protection, publicity of information, tacit consent, etc.
Carmen Cannavale, Assunta De Rosa, Emanuil Yordanov, Iva Parvova, Emil Hristov, Valentina Petkova   +5 more
doaj   +3 more sources